These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7423200)

  • 1. Gene splicing company wows Wall Street.
    Wade N
    Science; 1980 Oct; 210(4469):506-7. PubMed ID: 7423200
    [No Abstract]   [Full Text] [Related]  

  • 2. Genentech makes splash on Wall Street.
    Dickson D
    Nature; 1980 Oct; 287(5784):669-70. PubMed ID: 6933314
    [No Abstract]   [Full Text] [Related]  

  • 3. Cloning gold rush turns basic biology into big business.
    Wade N
    Science; 1980 May; 208(4445):688-92. PubMed ID: 6929110
    [No Abstract]   [Full Text] [Related]  

  • 4. Swiss company takes a 60 per cent stake in Genentech.
    Gershon D
    Nature; 1990 Feb; 343(6258):495. PubMed ID: 2300193
    [No Abstract]   [Full Text] [Related]  

  • 5. From lab bench to Wall Street.
    Bartfai T
    FASEB J; 2006 Aug; 20(10):1578-80. PubMed ID: 16873880
    [No Abstract]   [Full Text] [Related]  

  • 6. The microbiological production of pharmaceuticals.
    Aharonowitz Y; Cohen G
    Sci Am; 1981 Sep; 245(3):140-52. PubMed ID: 6116278
    [No Abstract]   [Full Text] [Related]  

  • 7. A revolution in biology.
    Abelson J
    Science; 1980 Sep; 209(4463):1319-21. PubMed ID: 6251541
    [No Abstract]   [Full Text] [Related]  

  • 8. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selling growth drug for children: the legal and ethical questions.
    Kolata G
    N Y Times Web; 1994 Aug; ():A1, A13. PubMed ID: 11647981
    [No Abstract]   [Full Text] [Related]  

  • 10. Genentech faces the consequences of growth.
    Ransom J
    Nat Biotechnol; 2007 Apr; 25(4):371. PubMed ID: 17420731
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene splicing to protect crop roots.
    Miller JA
    Sci News; 1984 Dec; 126(24):373. PubMed ID: 11653587
    [No Abstract]   [Full Text] [Related]  

  • 12. Wall Street and clinical trials.
    Steinbrook R
    N Engl J Med; 2005 Sep; 353(11):1091-3. PubMed ID: 16162879
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotechnology: interferon patent contested.
    Earl C; Beardsley T
    Nature; 1984 Mar 1-7; 308(5954):7. PubMed ID: 6199674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bitter battle over insulin gene.
    Marshall E
    Science; 1997 Aug; 277(5329):1028-30. PubMed ID: 9289846
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy's growing pains.
    Marshall E
    Science; 1995 Aug; 269(5227):1050, 1052-5. PubMed ID: 7652552
    [No Abstract]   [Full Text] [Related]  

  • 16. Company tried to bar report that H.I.V. vaccine failed.
    Hilts PJ
    N Y Times Web; 2000 Nov; ():A24. PubMed ID: 12159838
    [No Abstract]   [Full Text] [Related]  

  • 17. Genentech caps cost of cancer drug for some patients.
    Pollack A
    N Y Times Web; 2006 Oct; ():C2. PubMed ID: 17061339
    [No Abstract]   [Full Text] [Related]  

  • 18. Cochrane at crossroads over drug company sponsorship.
    Moynihan R
    BMJ; 2003 Oct; 327(7420):924-6. PubMed ID: 14563759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene goldrush splits Harvard, worries brokers.
    Wade N
    Science; 1980 Nov; 210(4472):878-9. PubMed ID: 6933694
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gene cloning].
    Kuchino Y
    Nihon Rinsho; 1982; 40(8):1758-65. PubMed ID: 7143749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.